Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes-Reference-Cited by-同舟云学术

Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes

Published:2018-03-16 Issue:6 Volume:144 Page:1037-1047
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Lin Peipei,Luo Yingwan,Zhu Shuanghong,Maggio Dominic,Yang Haiyang,Hu Chao,Wang Jinghan,Zhang Hua,Ren Yanling,Zhou Xinping,Mei Chen,Ma Liya,Xu Weilai,Ye Li,Zhuang Zhengping,Jin Jie,Tong Hongyan^ORCID

Funder

the National Key Technology R&D Program

National Natural Science Foundation of China Grants

National Public Health Grand Research Foundation

Major Program Fund of the Science Technology Department of Zhejiang Province

the Foundation of Innovation Team for Basic and Clinical Research of Zhejiang Province

Zhejiang Province Fund for Distinguished Young Scholars

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s00432-018-2627-3/fulltext.html

Reference47 articles.

1. Ahmad F, Mohota R, Sanap S, Mandava S, Das BR (2014) Molecular evaluation of DNMT3A and IDH1/2 gene mutation: frequency, distribution pattern and associations with additional molecular markers in normal karyotype Indian acute myeloid leukemia patients. Asian Pac J Cancer Prev: APJCP 15:1247–1253

2. Bejar R et al (2011) Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med 364:2496–2506. https://doi.org/10.1056/NEJMoa1013343

3. Cazzola M, Malcovati L (2005) Myelodysplastic syndromes—coping with ineffective hematopoiesis. N Engl J Med 352:536–538. https://doi.org/10.1056/NEJMp048266

4. Chen C et al (2013) Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition. Genes Dev 27:1974–1985. https://doi.org/10.1101/gad.226613.113

5. Choi C et al (2012) 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat Med 18:624–629. https://doi.org/10.1038/nm.2682

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of gene mutation characteristics and its correlation with prognosis in patients with myelodysplastic syndromes;Clinica Chimica Acta;2024-02

2. Molecular testing in myelodysplastic syndromes;Diagnostic Molecular Pathology;2024

3. The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia;International Journal of Molecular Sciences;2023-03-17

4. IDH2: A novel biomarker for environmental exposure in blood circulatory system disorders (Review);Oncology Letters;2022-06-24

5. The Prognostic Value of Pretherapy Peripheral Blood Inflammatory Indices in Myelodysplastic Syndromes;Frontiers in Oncology;2022-04-26